Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Gastroenterology|March 17, 2006
Therapy of NAFLD: insulin sensitizing agentsStephen H Caldwell, Curtis K Argo, Abdullah M S Al-Osaimi
World Journal of Hepatology|June 1, 2022
Late polymicrobial transjugular intrahepatic portosystemic shunt infection in a liver transplant patient: A case reportIrene Caridad Perez, Ziv J Haskal, John I Hogan, et al.
World Journal of Hepatology|February 2, 2017
Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohortLukasz A Myc, Jonathan G Stine, Rinita Chakrapani, et al.
Gastrointestinal Endoscopy|September 22, 2010
Mortality after percutaneous endoscopic gastrostomy in patients with cirrhosis: a case seriesJoseph G Baltz, Curtis K Argo, Abdullah M S Al-Osaimi, et al.
Journal of Clinical Gastroenterology|March 26, 2009
Thiazolidinediones for the treatment in NASH: sustained benefit after drug discontinuation?Curtis K Argo, Julia C Iezzoni, Abdullah M S Al-Osaimi, et al.
Journal of Clinical Gastroenterology|March 17, 2006
Therapy of NAFLD: antioxidants and cytoprotective agentsCharissa Y Chang, Curtis K Argo, Abdullah M S Al-Osaimi, et al.
Annals of Hepatology|November 9, 2010
Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesionsTimothy M Schmitt, Sean C Kumer, Neeral Shah, et al.
Journal of Hepatology|June 9, 2009
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitisCurtis K Argo, Patrick G Northup, Abdullah M S Al-Osaimi, et al.
Journal of Clinical and Translational Hepatology|January 26, 2016
Patients with Gastric Antral Vascular Ectasia (GAVE) Are at a Higher Risk of Gastrointestinal Bleeding in the Absence of CirrhosisJennifer Wang, Jonathan G Stine, Scott L Cornella, et al.
Pageof 6